TD Asset Management
CGON icon

TD Asset Management’s CG Oncology CGON Stock Holding History

TD Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Sell
183,756
-105,000
-36% -$6.86M 0.01% 596
2026
Q1 		$19.5M Buy
288,756
+102,308
+55% +$5.8M 0.02% 511
2025
Q4 		$7.74M Buy
186,448
+35,272
+23% +$1.46M 0.01% 721
2025
Q3 		$6.09M Sell
151,176
-52,696
-26% -$1.53M ﹤0.01% 753
2025
Q2 		$5.3M Buy
203,872
+135,566
+198% +$3.27M ﹤0.01% 760
2025
Q1 		$1.67M Sell
68,306
-10,878
-14% -$306K ﹤0.01% 1004
2024
Q4 		$2.27M Buy
79,184
+8,348
+12% +$286K ﹤0.01% 974
2024
Q3 		$2.68M Sell
70,836
-22,248
-24% -$780K ﹤0.01% 938
2024
Q2 		$2.94M Buy
+93,084
New +$3.23M ﹤0.01% 883

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TD Asset Management's CGON Position: Q2 2026 in Review

TD Asset Management reduced its CG Oncology (CGON) stake by 36% in Q2 2026, selling an estimated $6.86M and leaving 183,756 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #596.

TD Asset Management first reported a position in CGON in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.5M in Q1 2026. 226 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • TD Asset Management held 183,756 shares of CG Oncology worth $13.1M as of Q2 2026.
  • TD Asset Management sold 105,000 CG Oncology shares in Q2 2026, an estimated $6.86M.
  • CG Oncology made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #596 holding.
  • TD Asset Management first reported a position in CG Oncology in Q2 2024 and has held it in 9 quarters since.
  • TD Asset Management's CG Oncology position peaked at $19.5M in Q1 2026.
  • 226 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.